Texolifplus

Texolifplus

Tranexamic Acid, a lysine analog, hemostatic plasminogen activation inhibitor with anti-fibrinolytic and anti-hemophilic properties.
Tranexamic Acid acts by exerting antifibrinolytic effect by forming a reversible complex with plasminogen and displaces plasminogen from the fibrin surface and blocks it’s action on fibrin.
Ethamsylate exerts hemostatic action by acting on 1 step of haemostasis and restores capillary resistance and capillary wall stability & also reduces capillary bleeding and corrects abnormal platelet tunction.

• Company :

  LIFORIN PHARMACEUTICAL

• Component :

  Etamsylate 250mg + Tranexamic Acid 500mg Tablets

• Unit :

  Tablets